After a post-earnings stock dip, Netflix is betting on itself with a $25 billion buyback — a move that tells quite a story ...

Regeneron Pharmaceuticals' board has added $3 billion to the biotechnology company's stock-buyback program. Regeneron on Wednesday said the new authorization adds to the $688 million remaining under ...

Standard Premium Finance Holdings, Inc. (OTCQX: SPFX) (“Standard Premium”), a leading specialty finance company, today ...

Associated Banc-Corp (NYSE: ASB) ("Associated") today announced the results of the actions taken at its 2026 Annual Meeting ...

Now that it doesn’t have to pay for Warner Bros., Netflix is using its capital to buy back more shares: The streaming giant ...

Investor sentiment has weighed on Netflix stock since late last year, as the company navigated several high-profile ...

Slide Insurance Holdings, Inc. ('Slide” or the 'Company”) (Nasdaq: SLDE) today announced that its Board of Directors has ...

ESTERO, FL / ACCESS Newswire / April 27, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the ...

Netflix’s board has added $25 billion to the streaming giant’s stock-buyback program.

Netflix's stock is down more than 16 percent over the past six months.

Associated Banc-Corp (NYSE: ASB) ("Associated") today announced the results of the actions taken at its 2026 Annual ...

Netflix's board of directors has authorized a stock buyback of an additional $25 billion. The move comes as the company looks ...